EUVIMEDOtkrijte EUVIMED
Crossref

Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of CHRNA9 and IGF1R

Yung-Che Kuo iD, Chi-Long Chen iD, Kha-Liang Lee, Hsiao-Feng Wang, Victor James Drew, Pei-Chi Lan, Yuan-Soon Ho, Yen-Hua Huang iD

The Journal of Pathology · 2025

DOI: 10.1002/path.6423 ↗

At a glance

Journal article in The Journal of Pathology, 2025. Written by Yung-Che Kuo and 7 co-authors. Institution: TMU Research Center for Cell Therapy and Regeneration Medicine, Taipei Medical University, Taipei, Taiwan. Major MEDLINE topics: Triple Negative Breast Neoplasms, Nicotine, Receptor, IGF Type 1, Receptors, Nicotinic. Cited 5 times so far (Crossref); 59 references. Funded by: Ministry of Health and Welfare, Taiwan (Health and Welfare Surcharge of Tobacco Products), Taipei Medical University, National Science and Technology Council, Taiwan.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Cigarette smoking is a significant risk factor for cancer development with complex mechanisms. This study aims to investigate the impact of nicotine exposure on the regulation of stemness‐ and metastasis‐related properties via cholinergic receptor nicotinic alpha 9 subunit (CHRNA9) and insulin‐like growth factor‐1 receptor (IGF1R) and to evaluate their therapeutic potential in triple‐negative breast cancer (TNBC). We performed Kaplan–Meier survival analysis of public databases and revealed that high expression of CHRNA9, IGF1R signaling molecules, and stemness genes was significantly associated with poor recurrence‐free survival (RFS) and distant metastasis‐free survival (DMFS) in TNBC samples. Additionally, we examined two patient cohorts to determine the clinical associations between the expression levels of different genes ( n = 67) and proteins ( n = 42) and showed a strong positive correlation between the expression levels of CHRNA9, IGF1R signaling molecules, and stemness markers POU5F1/NANOG in tumor tissues. We carried out nicotine treatment and knockdown of CHRNA9 and IGF1R in TNBC cells to identify the effects on stemness‐related properties in vitro . Furthermore, primary and secondary metastatic in vivo animal models were examined using micro‐computed tomography (μCT) screening and in situ hybridization with a human Alu probe to detect tumor cells. Nicotine was found to upregulate the expression of CHRNA9, POU5F1, and IGF1R, influencing stemness‐ and metastasis‐related properties. Knockdown of CHRNA9 expression attenuated nicotine‐induced stemness‐related properties in a TNBC cell model. Furthermore, knockdown of IGF1R expression significantly alleviated nicotine/CHRNA9‐induced stemness features and cancer cell metastasis in cell cultures and lung metastatic mouse models. These results demonstrate that nicotine triggers IGF1R signaling, thereby enhancing stemness‐related properties, cell migration, invasion, and tumor metastasis, resulting in a poorer prognosis for patients with TNBC. These findings highlight IGF1R as a promising therapeutic target for reducing stemness and metastasis in TNBC patients exposed to environmental nicotine. © 2025 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Triple Negative Breast NeoplasmsNicotineReceptor, IGF Type 1Receptors, NicotinicNeoplastic Stem CellsHumansFemaleAnimalsCell Line, TumorGene Expression Regulation, NeoplasticSignal TransductionMiceCell Movement

Author keywords

CHRNA9IGF1RPOU5F1TNBCsmetastasisnicotinerecurrencestemnesssurvival

Substances

NicotineReceptor, IGF Type 1IGF1R protein, humanReceptors, NicotinicCHRNA9 protein, human

Authors and institutions

  • TMU Research Center for Cell Therapy and Regeneration Medicine, Taipei Medical University, Taipei, Taiwan.
  • Core Laboratory of Good Tissue Practice, Office of Research and Development, Taipei Medical University, Taipei, Taiwan.
  • Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Pathology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
  • Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Taipei Neuroscience Institute, Taipei Medical University, Taipei, Taiwan.

ORCID profiles: Yung-Che Kuo, Chi-Long Chen, Yen-Hua Huang

Funding

  • Ministry of Health and Welfare, Taiwan (Health and Welfare Surcharge of Tobacco Products)
  • Taipei Medical University
  • National Science and Technology Council, Taiwan
  • China Medical University

Cite

APA

Kuo, Y. C., Chen, C. L., Lee, K. L., Wang, H. F., Drew, V. J., Lan, P. C., Ho, Y. S., & Huang, Y. H. (2025). Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of CHRNA9 and IGF1R. The Journal of Pathology. https://doi.org/10.1002/path.6423

Vancouver

Kuo YC, Chen CL, Lee KL, Wang HF, Drew VJ, Lan PC, et al. Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of CHRNA9 and IGF1R. The Journal of Pathology. 2025. doi:10.1002/path.6423

BibTeX
@article{Kuo2025,
  author = {Kuo, Yung-Che and Chen, Chi-Long and Lee, Kha-Liang and Wang, Hsiao-Feng and Drew, Victor James and Lan, Pei-Chi and Ho, Yuan-Soon and Huang, Yen-Hua},
  title = {Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of CHRNA9 and IGF1R},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6423}
}
Start for free →